When I was a college freshman in the early 1990s, I lived in a dorm that was as sterile as a hospital room, a 193-square-foot box with white cinderblock walls that I shared with two other guys. The bathroom was also shared—with an entire floor.
With competition for tuition money ramping up, colleges are looking for ways to set themselves apart and some have turned to investing in unimaginable campus experiences, from water parks to luxurious residence halls.
In the economic report, “College as a Country Club,” published last year by the National Bureau of Economic Research, researchers found that some colleges -- excluding elite schools like Princeton and Yale -- attract more applicants when they invest in state-of-the-art facilities like pools and rec centers.
Featuring more than 100,000 private jets, yachts, exotic cars, exclusive watches and luxury homes from more than 3,600 trusted dealers around the world. JamesEdition helps you find the best of the best, whether you are in the market to buy or to find the perfect private jet or luxury yacht to charter.
Miami International Boat Show 2018
Temperatures are rising again and winter is officially over soon. The Miami International Boat Shows is the first Yacht Show in 2018 where we say it's worth going. Not only is Miami a perfect sunny place for living but also for taking a boat to th...
Can businesses save money with private jet charter?
Insuring a helicopter can be an easy process when dealing with the right agent. We have specialized in helicopter insurance and have been active with helicopter organizations since 1950. Travers & Associates is a member of Helicopter Association International (HAI) and uses its 58 plus years of insuring rotor wing aircraft to negotiate the best price and policy for you, our customer.
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that comprise the Department of Health and Human Services (HHS). NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of NCI and created the National Cancer Program.
Imatinib has been found to substantially improve outcomes in patients with chronic myeloid leukemia (CML) compared with previously available therapies. However, its use is complicated by development of resistance or drug intolerance, prompting dose escalation or a trial of dasatinib or nilotinib, the second-generation tyrosine kinase inhibitors (TKIs).
This article reviews the mechanisms of TKI resistance; discusses the tolerability and efficacy of high-dose imatinib, dasatinib, and nilotinib; and provides background for the rational use of second-line treatment options.